The cost effectiveness of empiric intravenous immunoglobulin for the antepartum treatment of fetal and neonatal alloimmune thrombocytopenia
- 30 September 2005
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 193 (3) , 1094-1099
- https://doi.org/10.1016/j.ajog.2005.05.048
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- European collaborative study of the antenatal management of feto‐maternal alloimmune thrombocytopeniaBritish Journal of Haematology, 2003
- Serial aggressive platelet transfusion for fetal alloimmune thrombocytopenia: Platelet dynamics and perinatal outcomeAmerican Journal of Obstetrics and Gynecology, 2002
- Initial fetal platelet counts predict the response to intravenous gammaglobulin therapy in fetuses that are affected by PLA1 incompatibilityAmerican Journal of Obstetrics and Gynecology, 2001
- A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopeniaAmerican Journal of Obstetrics and Gynecology, 2001
- Fetal Alloimmune ThrombocytopeniaNew England Journal of Medicine, 1997
- Antenatal management of alloimmune thrombocytopenia with intravenous γ-globulin: A randomized trial of the addition of low-dose steroid to intravenous γ-globulinAmerican Journal of Obstetrics and Gynecology, 1996
- Alloimmune thrombocytopenia: Fetal and neonatal losses related to cordocentesisAmerican Journal of Obstetrics and Gynecology, 1995
- 348 CASES OF SUSPECTED NEONATAL ALLOIMMUNE THROMBOCYTOPENIAThe Lancet, 1989
- Antenatal Treatment of Neonatal Alloimmune ThrombocytopeniaNew England Journal of Medicine, 1988
- In Utero Cerebral Hemorrhage in Alloimmune ThrombocytopeniaJournal of Pediatric Hematology/Oncology, 1986